We studied the effect of topically applied phenytoin on the healing of a decubitus ulcer in the sacral region of an immobile patient with stroke. Another similar, but smaller, ulcer was treated with conventional treatment only and served as a control. The ulcers were measured once a week and biopsies were taken from the margins before, 1 week and 2 weeks after commencing treatment with phenytoin. Clinically, phenytoin substantially accelerated the rate of healing. Microscopic examination of the biopsies showed increased lymphocytic infiltration of the phenytointreated lesion. Anti-CD31 immunohistochemistry revealed dense CD31+ lymphocytic infiltration and increased angiogenesis only in the phenytointreated lesion. Our findings suggest that phenytoin enhances wound healing by stimulating lymphocytic chemotaxis and up-regulation of angiogenesis.
ModeerTDahllofGTheorellK: Oral health in non-institutionalized epileptic children with special reference to phenytoin medication. Community Dent Oral Epidemiol1986; 14: 165–168
2.
DahlofGModeerTOtteskogPSundqvistKG: Subpopulations of lymphocytes in phenytoin-induced gingival overgrowth and gingivitis in children. Scand J Dent Res1985; 93: 507–512
3.
ModeerTDahllofGKarstenJOtteskogP: Potentiation of fibroblast proliferation by a phenytoin-induced mononuclear cell derived factor in vitro.Scand J Dent Res1989; 97: 186–187
4.
DaCostaMLReganMCal SaderMLeaderMBouchier-HayesD: Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds. Surgery1998; 123: 287–293
5.
DahllofGPreberHEliassonSRydenHKasrtenJModeerT: Periodontal condition of epileptic adults treated long-term with phenytoin or carbamazepine. Epilepsia1993; 34: 960–964
6.
ShapiroM: Acceleration of gingival wound healing in nonepileptic patients receiving diphenylhydantoin sodium (dilantin, epanutin). Exp Med Surg1958; 167: 41–53
7.
VijayasinghamSMDykesPJMarksR: Phenytoin has little effect on in-vitro models of wound healing. Br J Dermatol1991; 125: 136–139
8.
PendseAKSharmaASodaniAHadaS: Topical phenytoin in wound healing. Int J Dermatol1993; 32: 214–217
9.
LodhaSCLohiyaMLVyasMCRBhandariSGoyalRRHarshMK: Role of phenytoin in healing of large abscess cavities. Br J Surg1991; 78: 105–108
10.
MenezesJRajendranAJacobAJWVazM: The use of topical phenytoin as an adjunct to immobilization in the treatment of trophic leprosy ulcers. Southeast Asian J Trop Med Public Health1993; 24: 340–342
RhodesRSHeynemanCACulbertsonVLWilsonSEPhatakHMTopical phenytoin treatment of stage II decubitus ulcers in the elderly. Ann Pharmacother2001; 35: 675–681
13.
MatsuoAYajimaT: Cell proliferation and collagen fibrogenesis of cultured fibroblasts. Jpn J Oral Biol1985; 27: 56–63
14.
el ZayatSG: Preliminary experience with topical phenytoin in wound healing in a war zone. Mil Med1989; 154: 178–180
15.
ZocchiMRFerreroELeoneBERoverePBianchiEToninelliE: CD31/PECAM-1 driven chemokine-independent transmigration of human T-lymphocytes. Eur J Immunol1996; 26: 759–767
16.
PialiLHammelPUherekCBachmannFGislerRHDunonD: CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol1995; 130: 451–460
EliasCGIIISpellbergJPKaran-TamirBLinCHWangYJMcKennaPJ: Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur J Immunol1998; 28: 1948–1958
19.
GiatromanolakiAKoukourakisMTheodossiouDBarbatisCHarrisALGatterKCComparative evaluation of angiogenesis assessment with anti-Factor VIII and anti-CD31 immunostaining in non small cell lung cancer. Clin Cancer Res1997; 3: 2485–2492
20.
GiatromanolakiAKoukourakisMIKaklamanisLKakolyrisSBarbatisKTheodossiouD: Focal thymidine phosphorylase expression associates with local neoangiogenesis and CD31 positive lymphocytic aggregation in non small cell lung cancer. Anticancer Res1998; 18: 71–76
21.
GiatromanolakiAStathopoulosGPTsiobanouEPapadimitriouCGeorgouliasVGatterKC: Combined role of angiogenesis, bcl-2 and p53 expression in the prognosis of colorectal cancer. Cancer1999; 86: 1421–1430
22.
SalvenPMustjokiSAlitaloRAlitaloKRafiiS: VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood2003; 101: 168–172
